Negara: Irlandia
Bahasa: Inggris
Sumber: HPRA (Health Products Regulatory Authority)
SODIUM ACETATE TRIHYDRATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE HEXAHYDRATE ; SODIUM HYDROXIDE
Fresenius Kabi Limited
B05BB01
SODIUM ACETATE TRIHYDRATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE HEXAHYDRATE ; SODIUM HYDROXIDE
Unknown
Solution for Infusion
For intravenous use
10 x 500 ml, 20 x 500 ml, 10 x 1000 ml
Product subject to prescription which may not be renewed (A)
Fresenius Kabi Deutschland GmbH
Electrolytes
electrolytes
Ionolyte is indicated for: - Predominantly extracellular dehydration, regardless of cause (vomiting, diarrhea, fistulas, etc.) - Hypovolemia regardless of cause (hemorrhagic shock, burns, peri-operative water and electrolyte loss) - Mild metabolic acidosis
Not Marketed
2015-10-02
IONOLYTE SOLUTION FOR INFUSION V001/FB Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Ionolyte is and what it is used for 2. What you need to know before you are given Ionolyte 3. How you are given Ionolyte 4. Possible side effects 5. How to store Ionolyte 6. Contents of the pack and other information 1. WHAT IONOLYTE IS AND WHAT IT IS USED FOR Ionolyte is a Solution for infusion. Ionolyte is used for the treatment of: • extracellular dehydration (water loss) • hypovolaemia (sudden drop in volume of circulating blood) • mild metabolic acidosis (increased acid in the blood caused by a metabolic disorder). 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN IONOLYTE DO NOT USE IONOLYTE • if you are allergic to Sodium acetate trihydrate, Sodium chloride, Potassium chloride, Magnesium chloride hexahydrate or any of the other ingredients of this medicine (listed in section 6). 1 PACKAGE LEAFLET: INFORMATION FOR THE USER 0xxxxx1_00_Ionolyte_Kabipac_PB 01.09.2015 16:51 Seite 1 YOU SHOULD NOT RECEIVE IONOLYTE IF YOU HAVE • hyperhydration (too much fluid in the body), especially in cases of pulmonary oedema (fluid accumulation in the lungs) and congestive cardiac failure (your heart cannot pump enough blood througout the body) • severely impaired kidney function • metabolic alkalosis (decreased acidity of the blood caused by a metabolic disorder) • hyperkalaemia (too high blood levels of potassium) Your doctor will check these. Special care will be taken with Ionolyte if • you have heart failure • you have severe heart rate disorders • you have impaired kidney function • you have severe electrolyte abnormalities (e.g. too high Baca dokumen lengkapnya
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ionolyte solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The solution for infusion contains: 500 ml 1000 ml Sodium acetate trihydrate 2.32 g 4.63 g Sodium chloride 3.01 g 6.02 g Potassium chloride 0.15 g 0.30 g Magnesium chloride hexahydrate 0.15 g 0.30 g Electrolytes: Na+ 137.0 mmol/l K+ 4.0 mmol/l Mg++ 1.5 mmol/l Cl- 110.0 mmol/l CH3COO- 34.0 mmol/l Theoretical osmolarity: 286.5 mOsm/l Titrable acidity: < 2.5 mmol NaOH/l pH: 6.9 – 7.9 For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for infusion A clear and colourless solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ionolyte is indicated for: - Predominantly extracellular dehydration, regardless of cause (vomiting, diarrhea, fistulas, etc.) - Hypovolemia regardless of cause (hemorrhagic shock, burns, peri-operative water and electrolyte loss) - Mild metabolic acidosis 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults and paediatric patients The dose and rate of administration depends on age, body weight, clinical and biological conditions of the patient (including acid-base balance) and the concomitant therapy. Recommended dosage: The maximum daily dose corresponds to the fluid and electrolyte needs of the patient. To temporary restore blood H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _7_ _/_ _0_ _6_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _2_ _1_ _7_ _3_ _5_ _8_ _2_ _p_ _a_ _g_ _e_ _ _ _n_ _ Baca dokumen lengkapnya